• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.29% Nasdaq Down 0.03%

    Antares Pharma Inc. (ATRS)

    -NasdaqCM
    2.14 Up 0.04(1.90%) May 22, 4:00PM EDT
    Add to Portfolio
    Prev Close:2.10
    Open:N/A
    Bid:N/A
    Ask:2.16 x 2000
    1y Target Est:4.75
    Beta:1.86
    Earnings Date:Aug 5 - Aug 10 (Est.)
    Day's Range:2.08 - 2.17
    52wk Range:1.82 - 3.20
    Volume:1,628,335
    Avg Vol (3m):698,836
    Market Cap:324.75M
    P/E (ttm):N/A
    EPS (ttm):-0.27
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ATRSUp 1.90%324.75M
    BDXDown 0.33%29.72B
    BJCTDown 3.26%1.51M

    Key Statistics

    Forward P/E (1 yr):19.45
    P/S (ttm):10.44
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.12
    Quarterly EPS Est (Jun-15) :-0.03
    Mean Recommendation*:1.3
    PEG Ratio (5 yr expected):-0.22

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Antares Pharma, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback